SAN DIEGO (AP) _ The Kansas Bioscience Authority is providing $3.7 million for research on cancer, HIV and osteoporosis as well as increased development of new medicines.
The state-created agency announced the investments at a convention in San Diego on Wednesday, saying it hopes to highlight the existing capacity for bioscience research in Kansas.
Lenexa-based ImmunoGenetix Therapeutics Inc. will receive $420,000 to help with a vaccine designed to improve immune responses in patients who are HIV-positive. OsteoGeneX of Kansas City, Kan., will get $375,000 for research on osteoporosis and other bone disorders. Other grantees will receive money to build drug-testing labs and cancer treatments.
The authority is also offering $2.5 million to attract national cancer researchers to work with researchers in Kansas.
(Copyright 2008 by The Associated Press. All Rights Reserved.)